The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Fri., Dec. 6, 1:12 PM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #85. Perrigo Company plc OTC Products In Australia

Acquirer: Perrigo Company plc (NYSE:PRGO)
Acquiree: OTC Products In Australia
Details: Perrigo Company plc (NYSE: PRGO;TASE) announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc. for $51 million in cash. The products are primarily sold through the mass retail channel and include the Herron range of analgesics, vitamins and supplements. This basket of products is expected to generate at least $20 million in annual revenue.

Perrigo is a global healthcare company. Co. is a producer of generic pharmaceutical topical products such as creams, lotions, gels, and nasal sprays. Co.'s segments are: Consumer Healthcare Americas, which provides products for analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritionals, smoking cessation, animal health, vitamins, minerals and dietary supplements, and other miscellaneous healthcare products; Consumer Healthcare International, which provides products for cough, cold, allergy, sinus, personal care and derma-therapeutics, and anti-parasite; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.

Perrigo SEC Filing Email Alerts Service

Open the PRGO Page at The Online Investor »

Company Name: 
Perrigo Company plc
Drugs & Pharmaceuticals
Number of ETFs Holding PRGO: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the PRGO Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Hold (2.44 out of 4)
14th percentile
(ranked lower than approx. 86% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 85 of 100 Page |

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.